VOLPARA HEALTH TECHNOLOGIES LIMITED (VHT)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

VHT - VOLPARA HEALTH TECHNOLOGIES LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: March
GICS Industry Group : Health Care Equipment & Services
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.13

21 Sep
2021

-0.050

OPEN

$1.18

-4.24%

HIGH

$1.18

351,537

LOW

$1.13

TARGET
$1.87 65.5% upside
OTHER COMPANIES IN THE SAME SECTOR
ELX . PGC . AHZ . COH . FPH . IPD . LHC . NAN . RMD . SOM . HLA . MX1 . CAT . ONE . IDX . PME . CSX . 4DX . BRN . EMV . UBI . LDX . RAP . RVA . MEB . IME . PCK . CMP . CYC . IMR . VTI . OVN . EYE . AT1 . CBL .
FNARENA'S MARKET CONSENSUS FORECASTS
VHT: 1
Title FY22
Forecast
FY23
Forecast
EPS (cps) - 4.5 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio N/A xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in NZD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2021 FactSet UK Limited. All rights reserved
Title 20172018201920202021
EPS Basic xxxxxxxxxxxx-6.6
DPS All xxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxx18.4 M
Book Value Per Share xxxxxxxxxxxx26.7
Net Operating Cash Flow xxxxxxxxxxxx-13.1 M
Net Profit Margin xxxxxxxxxxxx-88.56 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 20172018201920202021
Return on Assets xxxxxxxxxxxx-20.72 %
Return on Equity xxxxxxxxxxxx-27.79 %
Return on Total Capital xxxxxxxxxxxx-31.01 %
Capex xxxxxxxxxxxx0.8 M
Capex % of Sales xxxxxxxxxxxx4.19 %
Free Cash Flow ex dividends xxxxxxxxxxxx-13.2 M

Return on Assets

Return on Equity

Return on Total Capital

Capex

Capex % of Sales

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

28/07/2021

1

Add

$1.87

65.49%

Morgans assesses momentum continues to build with record cash receipts and growing annual recurring revenue (ARR), after Volpara Health Technologies posted its first quarter cashflow report.

The broker highlights the focus on risk assessment and genetics has been enhanced with the recent CRA Health acquisition and collaboration with Invitae Corporation.

Morgans makes no changes to forecasts and maintains its $1.87 target price and Add rating.

FORECAST
Morgans forecasts a full year FY22 dividend of 0.00 cents and EPS of minus -4.47 cents.
Morgans forecasts a full year FY23 dividend of 0.00 cents and EPS of minus -0.47 cents.

VHT STOCK CHART